Searchable abstracts of presentations at key conferences in endocrinology

ea0085p65 | Diabetes 3 | BSPED2022

Use of artificial pancreas systems in routine clinical care is effective in improving glycaemic control in paediatric patients

Kaninde Abhidhamma , Kotak Janki , Collins Louise , Drummond Lesley , Pemberton John , Idkowiak Jan , Mohamed Zainaba , Dias Renuka , Saraff Vrinda , Kershaw Melanie , Krone Ruth

Introduction: Artificial pancreas systems (APS) have improved glycaemic control in adult and paediatric patients in clinical trials as part of routine clinical careAim and objectives: To evaluate the effectiveness of artificial pancreas system in routine clinical care on glycaemic control over a period of three to six months. Changes in glycated haemoglobin (HbA1c), time in range (TIR, 3.9-10 mmol/l) and time below range (TBR, <3.9 mmol/l) were asses...

ea0086p45 | Endocrine Cancer and Late Effects | SFEBES2022

Emergency Ambulatory Outpatient Management of Immune Checkpoint Inhibitor-mediated Hypocortisolaeamia

Ganawa Shawg , Muhammad Haris , Knight Tom , Dhage Shaishav , Hoong Ho Jan , Gupta Avinash , Lorigan Paul , Higham Claire , Cooksley Tim , Adam Safwaan

Background: Immunotherapy mediated adrenocorticotrpic hormone (ACTH) deficiency is an important toxicity related to immune-checkpoint inhibitors (ICPi) potentially resulting in significant morbidity. Early diagnosis and optimal management are essential and frequently necessitate inpatient hospital treatment. We have previously reported an ambulatory management pathway for ICPi-induced ACTH deficiency in 4 patients. We sought to report the outcomes of this pathway in a larger c...

ea0090p728 | Reproductive and Developmental Endocrinology | ECE2023

Polygenic Score for Dizygotic Twinning in Mothers of Spontaneously and Artificially Conceived Twins and Singletons

Hubers Nikki , Page Christian , Mbarek Hamdi , Lambalk Nils , Ligthart Lannie , Pool Rene , Jan Hottenga Jouke , van Dongen Jenny , Haberg Siri , Ehli Erik , Harris Jennifer , Willemsen Gonneke , Boomsma Dorret

Spontaneous dizygotic (DZ) twinning results from a double ovulation and runs in families indicating a genetic component. Endocrinology studies in mothers of DZ twins observed higher levels of follicle stimulation hormone (FSH) and FSHB was, together with SMAD3, one the first loci identified as genome wide significant in genome-wide association studies (GWAS) of having DZ twins. Several additional loci were recently found that indicate genes involved with fema...

ea0090ep732 | Pituitary and Neuroendocrinology | ECE2023

Pituitary metastasis in neuroendocrine neoplasms, lesson learned from cases reports

Ganawa Shawg , Ilyas Waqas , Irshad Shadman , Hamad Adeel , Pathmanaban Omar , Milanovic Dusan , Colaco Rovel , Blackhall Fiona , Valle Juan , Ho Jan Hoong , Adam Safwaan

Introduction: Pituitary metastases (PM) are an uncommon manifestation of Neuroendocrine neoplasms (NENs) and are rarely reported. We report two cases of PM with different clinical lessons.Case 1: A 37-year-old female underwent surgical resection for a high grade poorly differentiated neuroendocrine carcinoma of the cervix (Ki67 90%). Serial follow-up surveillance assessments revealed disease progression (local, liver, lung, and bone) for which she underw...

ea0063gp173 | Obesity (1) | ECE2019

Excellent tumor response to pasireotide therapy in an aggressive and dopamine-resistant prolactinoma

Coopmans Eva , van Meyel Sebastiaan , Pieterman Kay , van Ipenburg Jolique , Hofland Leo , Donga Esther , Daly Adrian , Beckers Albert , van der Lely Aart-Jan , Neggers Sebastian

Background: Prolactinomas are the most frequent secreting pituitary adenomas encountered in the clinical setting. Cabergoline is considered the mainstay medical treatment and transsphenoidal surgery (TSS) is recommended for patients that are medically resistant to dopamine agonist therapy. Resistance to dopamine agonists is commonly defined as failure to normalize prolactin and less than 50% decrease in tumor diameter at a maximal labeled dose of 2.0 mg/week. Pasireotide LAR (...

ea0063gp232 | Adrenal and Neuroendocrine - Clinical (1) | ECE2019

Can phthalates impair liver function?

Medic-Stojanoska Milica , Milosevic Natasa , Milanovic Maja , Stojanoski Stefan , Vukovic Bojan , Icin Tijana , Bajkin Ivana , Stepanovic Kristina , Sudji Jan , Milic Natasa

Introduction: The impairment of liver function and enhancement for NAFLD development may be attributed to the ubiquitous exposure to endocrine disrupting chemicals such as phthalates. In this study the urinary levels of monoethyl phthalate (MEP) and mono-(2-ethylhexyl) phthalate (MEHP) were compared with the parameters of hepatic function and lipids in overweight, diabetic patients and normal weight population.Methods and patients: In 305 volunteers of b...

ea0063p652 | Interdisciplinary Endocrinology 1 | ECE2019

Restoring the sleep disruption by blue light emitting screen use in adolescents: a randomized controlled trial

Meijden Wisse P van der , Stenvers Dirk Jan , Kerkhof Linda van , Nierop Lotte van , Steeg Harry van , Bisschop Peter H , Someren Eus J van , Kalsbeek Andries

Introduction: Adolescents spend much time using blue-light emitting screen devices such as smartphones, tablets and computers. Blue light affects the central circadian clock in the suprachiasmatic nucleus (SCN) as well as melatonin secretion by the pineal gland. Screen use in adolescents strongly associates with reduced sleep quality and sleep duration. However, there is a lack of intervention studies that reduce blue light exposure due to screen use in adolescents.<p clas...

ea0049gp192 | Pituitary &amp; endocrine Tumours | ECE2017

Long-term treatment with pegvisomant (Somavert®): Observations from 2090 acromegaly patients followed in ACROSTUDY

vanderLely Aart Jan , Biller Beverly , Brue Thierry , Buchfelder Michael , Ghigo Ezio , Pan kaijie , Jonsson Peter , Lavenberg Joanne , Strasburger Christian J. , Webb Susan , Camacho-Hubner Cecilia , Hey-Hadavi Judith

Introduction: Pegvisomant (PEGV) is approved for the treatment of acromegaly since 2003. This is the second interim analysis of data from ACROSTUDY, with the majority of patients treated for at least five years (yrs).Methods/design: ACROSTUDY is an international, open-label, prospective, non-interventional, post-marketing surveillance study monitoring the long-term safety and efficacy of PEGV. Patients were enrolled in the study on an ongoing basis.<...

ea0047oc43 | Innovative Theranostics | Theranostics2016

Initial South African experience on 68Ga/213Bi radiolabeling for prospective theranostics

Ebenhan Thomas , Suthiram Janine , Erasmus Danka , Knoesen Otto , Wagener Judith , Marjanovic-Painter Biljana , Zeevaart Jan Rijn , Marx Sebastian , Meckel Marian , Sathekge Mike M.

Background: The current focus of personalized medicine is towards the use of the theranostic approach – the development of an interdependent, collaborative targeted therapeutic and a companion diagnostic test. [DOTA0,D-Phe1,Tyr3]-octreotate (DOTA-TATE) and ligands targeting prostate-specific membrane antigen (PSMA) have been introduced recently as 177Lu-labeled theranostics for neuroendocrine tumors and prostate cancer respectiv...

ea0042p19 | (1) | Androgens2016

The AR/NCOA1 signaling regulates prostate cancer migration by involvement of PRKD1

Luef Birgit , Handle Florian , Kharaishvili Gvantsa , Hager Martina , Rainer Johannes , Janetschek Gunter , Hruby Stephan , Englberger Christine , Bouchal Jan , Santer Frederic R , Culig Zoran

Due to the urgent need for new prostate cancer (PCa) therapies, the role of androgen receptor (AR) interacting proteins should be investigated. In this study we aimed to address whether the AR coactivator nuclear receptor coactivator 1 (NCOA1) is involved in PCa progression. Therefore, we tested the effect of long-term NCOA1 knockdown on processes relevant to metastasis formation. [3H]-thymidine incorporation assays revealed a reduced proliferation rate in ...